Treatment of Obsessive-Compulsive Disorder by U.S. Psychiatrists.
J Clin Psychiatry 2006;67(6):946-951
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: To examine the treatment
of obsessive-compulsive disorder (OCD) by a nationally representative sample of psychiatrists.
Method: The authors analyzed
physician-reported data from the 1997 and 1999
American Psychiatric Institute for Research and
Education Practice Research Network (PRN) Study of
Psychiatric Patients and Treatments to describe demographic, clinical, and treatment
characteristics of patients with a diagnosis of OCD (per
DSM-IV and clinical features). On the basis of
published studies, serotonin reuptake inhibitor (SRI)
doses were predefined as low, intermediate, or high.
Results: Sixty-five percent of patients
received an SRI, but only 39.4% of the sample patients received an SRI at a dose thought to
be most effective for OCD or were having their
dose titrated. A total of 7.5% of patients in the
sample received cognitive-behavioral therapy (CBT)
with or without medication treatment. Prescription
of benzodiazepines or antipsychotics was common, often in the absence of an SRI. Patients
receiving CBT had on average the highest scores on
the Global Assessment of Functioning Scale. No other demographic or treatment
characteristics were associated with the type of treatment
received by the patients.
Conclusion: Despite important advances
in the efficacy of pharmacologic and psychological treatments for OCD, psychiatric care of
OCD continues to be an area with substantial
opportunity for quality improvement.